Non-protein stabilized clostridial toxin pharmaceutical compositions

Details for Australian Patent Application No. 2012202088 (hide)

Owner Allergan, Inc.

Inventors Hunt, Terrence J.

Agent Davies Collison Cave

Pub. Number AU-A-2012202088

Parent 2006299366

Filing date 11 April 2012

Wipo publication date 3 May 2012

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

3 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202088

3 May 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202089-Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

2012202087-Foil cartridge and method for producing a foil cartridge